Breaking News Instant updates and real-time market news.

BCS

Barclays

$9.74

0.655 (7.21%)

, BP

BP

$36.95

-0.005 (-0.01%)

10:39
12/15/19
12/15
10:39
12/15/19
10:39

Jefferies gives European investors 'Christmas list of 20 stocks for 2020'

Analysts at Jefferies presented a European "Christmas list of 20 stocks for 2020." There are 10 large cap buys, five mid-cap buys and five stocks that the firm thinks will underperform. The list of buys are Amadeus IT Group (AMADY), Anglo American (NGLOY), Barclays (BCS), BP (BP), BT Group (BT), Carlsberg (CABGY), Demant (WILYY), E.ON (EONGY), Intermediate Capital, Intertek (IKTSY), Novartis (NVS), Persimmon (PSMMY), Puma (PUMSY), RSA Insurance (RSNAY) and Koninklijke Vopak (VOPKY). The five European stocks that Jefferies thinks will underperform in 2020 are Hammerson (HMSNF), NMC Health (NMHLY), Reckitt Benckiser (RBGLY), Renault (RNLSY) and Securitas.

BCS

Barclays

$9.74

0.655 (7.21%)

BP

BP

$36.95

-0.005 (-0.01%)

AMADY

Amadeus IT Group

$0.00

(0.00%)

NGLOY

Anglo American

$0.00

(0.00%)

BT

BT Group

$0.00

(0.00%)

CABGY

Carlsberg

$0.00

(0.00%)

WILYY

Demant

$0.00

(0.00%)

EONGY

E.ON

$0.00

(0.00%)

IKTSY

Intertek

$0.00

(0.00%)

NVS

Novartis

$93.00

-0.055 (-0.06%)

PSMMY

Persimmon

$0.00

(0.00%)

PUMSY

Puma

$0.00

(0.00%)

RSNAY

RSA Insurance

$0.00

(0.00%)

VOPKY

Koninklijke Vopak

$0.00

(0.00%)

HMSNF

Hammerson

$0.00

(0.00%)

NMHLY

NMC Health

$0.00

(0.00%)

RBGLY

Reckitt Benckiser

$0.00

(0.00%)

RNLSY

Renault

$0.00

(0.00%)

  • 17

    Dec

  • 23

    Mar

BCS Barclays
$9.74

0.655 (7.21%)

09/05/19
KBWI
09/05/19
UPGRADE
KBWI
Market Perform
Barclays upgraded to Market Perform from Underperform at Keefe Bruyette
11/26/19
EXAN
11/26/19
UPGRADE
Target $195
EXAN
Outperform
Barclays upgraded to Outperform from Neutral at Exane BNP Paribas
Exane BNP Paribas analyst Guy Stebbings upgraded Barclays to Outperform from Neutral with a 195 GBp price target.
10/22/19
KBWI
10/22/19
UPGRADE
KBWI
Outperform
Barclays upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Edward Firth upgraded Barclays to Outperform from Market Perform with a price target of 175 pence.
11/01/19
11/01/19
NO CHANGE

Rice University-Jones Graduate School of Business to hold a summit
Rice Energy Finance Summit will be held in Houston on November 1.
BP BP
$36.95

-0.005 (-0.01%)

09/16/19
JPMS
09/16/19
NO CHANGE
JPMS
JPMorgan bullish on European oil stocks, sees demand 4% by 2040
Despite energy efficiency improvements in the West, global energy consumption is expected to continue to grow, led by Asia, JPMorgan analyst Christyan Malek tells investors in a research note. The analyst, who believes decarbonizing will be "far harder than current consensus assumes," estimates oil demand will be 4% higher than current levels by 2040, with demand growth peaking during 2035 through 2040. Amidst this backdrop, Malek has turned bullish on oil equities. The analyst's top pick is Royal Dutch Shell (RDS.A) and he reiterates an Overweight rating on BP (BP). Malek today upgraded Total (TOT) to Overweight from Neutral as he believes the company is best placed to reduce its own emissions intensity from core businesses and products and capture new sources of global energy demand growth. Malek also upgraded Equinor (EQNR) to Neutral from Underweight and following a period of restriction, moved to an Underweight from Neutral on Eni SpA (ENI) and Overweight rating on OMV AG (OMVKY).
10/31/19
10/31/19
DOWNGRADE

Hold
BP downgraded to Hold at Argus on rising debt levels
As previously reported, Argus analyst Bill Selesky downgraded BP (BP) to Hold from Buy. The analyst cites his concern with the company's current debt to capital ratio of 43%, which is well above those of ExxonMobil's (XOM) 18%, Chevron's (CVX) 18%, and Shell's (RDS.A) 32%. In a period of slower economic growth, Selesky says the elevated debt is a disadvantage and sees the company's less leveraged peers as better positioned in managing potentially lower energy prices. The analyst also lowers his FY19 and FY20 EPS views on BP by 38c and 40c to $2.94 and $3.38 respectively.
10/31/19
ARGS
10/31/19
DOWNGRADE
ARGS
Hold
BP downgraded to Hold from Buy at Argus
Argus downgraded BP to Hold from Buy.
AMADY Amadeus IT Group
$0.00

(0.00%)

07/22/19
JEFF
07/22/19
INITIATION
JEFF
Buy
Amadeus IT Group initiated with a Buy at Jefferies
Jefferies analyst Julian Serafini started Amadeus IT Group with a Buy rating and EUR 90 price target. The company is positioned for "another leg of growth" as it capitalizes on a EUR 1B-plus cross-sell opportunity in its airline IT business, says the analyst.
01/14/19
BREN
01/14/19
INITIATION
BREN
Buy
Amadeus IT Group initiated with a Buy at Berenberg
Berenberg analyst Georgios Kertsos initiated Amadeus IT Group with a Buy rating and EUR80 price target, stating that he believes its IT Solutions division is undervalued and deserves a SaaS multiple. He sees Amadeus as well positioned to disproportionately benefit versus peers, partly because it operates in the relatively more profitable European global distribution services market.
01/14/19
BREN
01/14/19
INITIATION
Target $18
BREN
Sell
Sabre initiated with a Sell at Berenberg
Berenberg analyst Georgios Kertsos initiated Sabre (SABR) with a Sell rating and $18 price target, stating that he expects the trend of deteriorating margins to persist and to limit DPS growth. He notes the IT Solutions division's "persistent underperformance" relative to Amadeus (AMADY) and is concerned that the recent trend of growth at the expense of profitability in Sabre's travel network division is unsustainable, Kertsos tells investors.
NGLOY Anglo American
$0.00

(0.00%)

12/13/19
FBCO
12/13/19
DOWNGRADE
Target $2170
FBCO
Neutral
Anglo American assumed with a Neutral from Outperform at Credit Suisse
Credit Suisse analyst Conor Rowley downgraded Anglo American to Neutral from Outperform after assuming coverage of the name. The analyst lowered his price target for the shares to 2,100 pence from 2,600 pence. Rowley notes the shares have outperformed year-to-date.
11/07/19
GSCO
11/07/19
DOWNGRADE
GSCO
Neutral
Anglo American downgraded to Neutral from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Eugene King downgraded Anglo American (NGLOY) to Neutral from Buy and removed the stock from Goldman's Conviction List with a price target of 2,200 pence, down from 2,300. Anglo is 25% off its August lows and its current valuation better reflects its forecasted returns profile, King tells investors in a research note. Rio Tinto (RIO) is now the analyst's top pick in Europe Metals & Mining.
05/28/19
HSBC
05/28/19
UPGRADE
HSBC
Buy
Anglo American upgraded to Buy from Hold at HSBC
05/24/19
RBCM
05/24/19
UPGRADE
RBCM
Top Pick
Anglo American upgraded to Top Pick from Outperform at RBC Capital
BT BT Group
$0.00

(0.00%)

12/06/19
UBSW
12/06/19
DOWNGRADE
Target $165
UBSW
Sell
BT Group downgraded to Sell from Neutral at UBS
UBS analyst Polo Tang downgraded BT Group to Sell from Neutral with a 165 GBp price target. The analyst sees rising competitive and political risks.
06/21/19
MKMP
06/21/19
NO CHANGE
Target $110
MKMP
Buy
WWE's India / Middle East / China TV deals still to be done, says MKM Partners
MKM Partners analyst Eric Handler kept his Buy rating and $110 price target on WWE (WWE) after the company's announcement of a renewed pay-TV deal in Latin America and a new partnership in the UK with BT (BT). The analyst states that the company's prior notice that it would disclose monetary value for all international TV deals when they are completed suggests that it is still in talks on contracts for its India, Middle East, and China markets. Handler adds that it would "not be surprising" if WWE was able to "claw back" its ability to sell some of U.K.'s free-to-air rights for possible extra monetization.
11/18/19
LEHM
11/18/19
DOWNGRADE
LEHM
Underweight
BT Group downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Maurice Patrick downgraded BT Group to Underweight from Equal Weight with a price target of 106 pence, down from 240 pence. The analyst sees increased competition as alternative networks accelerate their build-out of fiber to the home.
06/24/19
DBAB
06/24/19
DOWNGRADE
DBAB
Sell
BT Group downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank analyst Robert Grindle downgraded BT Group to Sell from Hold and lowered his price target to 175p from 217p, citing the threat to its EBITDA recovery from rising capital expenditures.
CABGY Carlsberg
$0.00

(0.00%)

06/27/19
SBSH
06/27/19
DOWNGRADE
SBSH
Sell
Carlsberg downgraded to Sell from Neutral at Citi
Citi downgraded Carlsberg to Sell from Neutral saying weather-related issues in Q2 will slow the company's earnings momentum.
04/02/19
LEHM
04/02/19
INITIATION
LEHM
Overweight
Carlsberg initiated with an Overweight at Barclays
Barclays analyst Laurence Whyatt started Carlsberg with an Overweight rating and 975 kroner price target.
09/10/19
BERN
09/10/19
UPGRADE
BERN
Market Perform
Carlsberg upgraded to Market Perform from Underperform at Bernstein
09/10/19
09/10/19
UPGRADE

Market Perform
Carlsberg upgraded to Market Perform at Bernstein
As previously reported, Bernstein analyst Trevor Stirling upgraded Carlsberg to Market Perform from Underperform on sector valuation. The analyst argues that the stable growth and highly cash-generative nature of European Beverages warrants a higher premium than was the case 10 years ago.
WILYY Demant
$0.00

(0.00%)

EONGY E.ON
$0.00

(0.00%)

10/08/19
DBAB
10/08/19
INITIATION
DBAB
Hold
E.ON initiated with a Hold rating at Deutsche Bank
Deutsche Bank started E.ON with a Hold rating and 9.20 euros price target.
08/27/19
LEHM
08/27/19
UPGRADE
LEHM
Overweight
E.ON upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Peter Crampton upgraded E.ON to Overweight from Equal Weight while lowering his price target for the shares to 9.50 euros from 10 euros.
12/02/19
GSCO
12/02/19
UPGRADE
Target $9.7
GSCO
Neutral
E.ON upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Alberto Gandolfi upgraded E.ON to Neutral from Sell with a price target of EUR 9.70, up from EUR 8.95. Expectations on the company's net debt have largely been reset and it has provided more visibility on pro forma profits following the recently completed acquisition of innogy, Gandolfi tells investors in a research note. He believes investor focus is now likely to shift away from debt and move to the 5% cash dividend yield.
10/31/19
JEFF
10/31/19
UPGRADE
JEFF
Buy
E.ON upgraded to Buy from Hold at Jefferies
Jefferies analyst Ahmed Farman upgraded E.ON to Buy from Hold with a price target of 10 euros. The analyst says the stock's over 10% valuation discount relative to peers is unwarranted given its network visibility.
IKTSY Intertek
$0.00

(0.00%)

11/19/19
JEFF
11/19/19
UPGRADE
JEFF
Buy
Intertek upgraded to Buy from Hold at Jefferies
Jefferies analyst William Kirkness upgraded Intertek to Buy from Hold with a price target of 6,100p, down from 6,300p, as his analysis of commentary and trends suggests an acceleration in the company's Business Assurance, Chem and Pharma and Building and Construction segments. While noting the stock is "a consensus underperform on the sell-side," he sees a compelling entry point as he believes Intertek is now in a position to demonstrate accelerating organic growth and margin improvements.
08/05/19
MSCO
08/05/19
DOWNGRADE
MSCO
Underweight
Intertek downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Edward Stanley downgraded Intertek to Underweight from Equal Weight while raising his price target for the shares to 52.50 pounds from 47 pounds.
11/12/19
GSCO
11/12/19
UPGRADE
GSCO
Neutral
Intertek upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Suhasini Varanasi upgraded Intertek to Neutral from Sell with a price target of 5,200 pence. The analyst cites valuation for the upgrade following the recent underperformance of the shares.
11/19/19
JEFF
11/19/19
UPGRADE
JEFF
Buy
Intertek upgraded to Buy from Hold at Jefferies
Jefferies analyst William Kirkness upgraded Intertek to Buy from Hold with a price target of 6,100 pence. The analyst sees a "compelling" entry point ahead of margin improvements and accelerating organic growth.
NVS Novartis
$93.00

-0.055 (-0.06%)

12/06/19
CANT
12/06/19
INITIATION
Target $34
CANT
Overweight
Gossamer Bio initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle initiated coverage of Gossamer Bio (GOSS) with an Overweight rating and $34 price target. The analyst sees a "compelling" setup into 2020. While the Luster data from Novartis (NVS) has significant stock moving potential for Gossamer, with upside potential of 75%-100% versus downside of 25%-50%, GB002 for pulmonary arterial hypertension could be a $2B peak sales opportunity with potential de-risking in the first half of 2020 "that deserves more focus," Merle tells investors in a research note.
12/04/19
BOFA
12/04/19
NO CHANGE
Target $104
BOFA
Buy
BofA/Merrill recommends investors buy Novartis on new product growth
BofA/Merrill analyst Graham Parry keeps his Buy rating and CHF104 price target on Novartis in spite of lowering his FY20 EPS view to $5.64 from $5.92 to reflect the dilution from its Medicines Co acquisition and expected completion of the US generics divestment to Aurobindo. The analyst cites the company's expected new launches and forecasts "premium growth" from its new products, saying its sales are set to rise about 7% in 2019-2022 thanks to its "16 key growth products and Pharma margin expansion" to 37.1% from 33.3% this year.
11/25/19
BARD
11/25/19
UPGRADE
Target $70
BARD
Outperform
Arrowhead upgraded to Outperform after Medicines Company takeover at Baird
As previously reported, Baird analyst Madhu Kumar upgraded Arrowhead Pharmaceuticals (ARWR) to Outperform from Neutral with a price target of $70, up from $39, after Medicines Company (MDCO) announced a definitive agreement to be acquired by Novartis (NVS). That deal forces Kumar to re-evaluate Arrowhead' RNAi platform, which is heavily levered to lipid-modifying RNAi drugs for cardiovascular disease, the analyst tells investors. Given the early positive efficacy for Arrowhead's ANGPTL3 and APOC3 RNAi drugs presented at the American Heart Association meeting, Kumar believes these programs have "the chance to dominate the ANGPTL3 and APOC3 landscapes," though cautions both are "quite early."
11/25/19
OPCO
11/25/19
DOWNGRADE
Target $85
OPCO
Perform
The Medicines Co. downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Jay Olson downgraded The Medicines Co. (MDCO) to Outperform from Perform with a price target of $85, up from $68, after it agreed to be acquired by Novartis (NVS) for $9.7B. After months of impressive data presentations for inclisiran and media reports of alleged negotiations with potential acquirers, Olson says that this this deal announcement brings welcomed news to The Medicines Co. investors who were patient enough to "weather an exciting ride."
PSMMY Persimmon
$0.00

(0.00%)

06/12/19
GSCO
06/12/19
INITIATION
GSCO
Buy
Persimmon initiated with a Buy at Goldman Sachs
07/23/19
BREN
07/23/19
UPGRADE
BREN
Buy
Persimmon upgraded to Buy from Hold at Berenberg
Berenberg analyst Sam Cullen upgraded Persimmon to Buy from Hold with a price target of 2,470p, down from 2,630p.
09/27/19
JEFF
09/27/19
UPGRADE
JEFF
Buy
Persimmon upgraded to Buy from Hold at Jefferies
Jefferies analyst Glynis Johnson upgraded Persimmon to Buy from Hold with a price target of 24.38 pounds citing the company's 11.1% dividend yield and "strong" cash position.
05/07/19
SBSH
05/07/19
UPGRADE
SBSH
Buy
Persimmon upgraded to Buy from Neutral at Citi
Citi upgraded Persimmon to Buy from Neutral.
PUMSY Puma
$0.00

(0.00%)

10/25/19
SOCG
10/25/19
DOWNGRADE
SOCG
Hold
Puma downgraded to Hold from Buy at Societe Generale
Societe Generale analyst Antoine Riou downgraded Puma to Hold from Buy with a price target of 73 euros.
08/05/19
FBCO
08/05/19
UPGRADE
FBCO
Neutral
Puma upgraded to Neutral from Underperform at Credit Suisse
Credit Suisse analyst Szilvia Bor upgraded Puma SE to Neutral from Underperform and raised her price target for the shares to 62 euros from 52 euros.
12/02/19
JEFF
12/02/19
INITIATION
Target $292
JEFF
Hold
Jefferies initiates European sporting brands, starts Adidas at Hold, Puma at Buy
Jefferies analyst James Grzinic initiated coverage of European sporting brands, starting Adidas (ADDYY) with a Hold rating and EUR 292 price target and Puma (PUMSY) with a Buy rating and EUR 83 price target. Grzinic calls Puma the "best Western play into China," stating that he is impressed by its Chinese ambitions, and while it is too early to fully assume a successful U.S. basketball relaunch, his estimates are 11% above FY21 consensus due to his more bullish view on China. On Adidas, he assumes "brand heat" will remain strong in the U.S. in 2020, but is "more circumspect" on Chinese mid-term prospects, Grzinic tells investors.
12/02/19
JEFF
12/02/19
INITIATION
Target $83
JEFF
Buy
Puma initiated with a Buy at Jefferies
Jefferies initiated coverage of Puma with a Buy rating and EUR 83 price target.
RSNAY RSA Insurance
$0.00

(0.00%)

02/14/19
JPMS
02/14/19
DOWNGRADE
JPMS
Neutral
RSA Insurance downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Edward Morris downgraded RSA Insurance to Neutral and lowered his price target for the shares to GBP 6.15 from GBP 6.55. The analyst expects challenges in the U.K. to weigh on estimates.
03/06/19
UBSW
03/06/19
UPGRADE
UBSW
Buy
RSA Insurance upgraded to Buy from Neutral at UBS
UBS analyst Jonny Urwin upgraded RSA Insurance to Buy and raised his price target for the shares to 600p from 550p. The company is well positioned to deliver against lower expectations, Urwin tells investors in a research note.
06/10/19
SBSH
06/10/19
UPGRADE
SBSH
Buy
RSA Insurance upgraded to Buy from Neutral at Citi
Citi analyst James Shuck upgraded RSA Insurance to Buy from Neutral and raised his price target for the shares to GBP 6.23 from GBP 5.66. The process of industrializing capital allocation at insurers has not yet been rewarded but is fully underway, Shuck tells investors in a research note. He believes this should drive less earnings volatility for European Insurance names as well as better cash management.
VOPKY Koninklijke Vopak
$0.00

(0.00%)

09/20/19
JEFF
09/20/19
UPGRADE
JEFF
Buy
Koninklijke Vopak upgraded to Buy from Hold at Jefferies
Jefferies analyst David Kerstens upgraded Koninklijke Vopak to Buy from Hold and raised his price target for the shares to 54 euros from 44 euros. The analyst believes the International Maritime Organisation 2020 regulations will drive a recovery in fuel oil storage and higher storage rates.
HMSNF Hammerson
$0.00

(0.00%)

06/21/19
STFL
06/21/19
UPGRADE
STFL
Hold
Hammerson upgraded to Hold from Sell at Stifel
Stifel analyst John Cahill upgraded Hammerson to Hold from Sell while lowering his price target for the shares to 2.80 pounds from 3 pounds.
09/16/19
GSCO
09/16/19
UPGRADE
GSCO
Buy
Hammerson upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Jonathan Kownator upgraded Hammerson to Buy from Neutral with a price target of 3.03 pounds, up from 2.88 pounds. Following their underperformance over the past 12 months, the shares fail to reflect the value of the company's Premium Outlets business, Kownator tells investors in a research note. He believes management has signaled they are considering options for the unit.
NMHLY NMC Health
$0.00

(0.00%)

RBGLY Reckitt Benckiser
$0.00

(0.00%)

07/05/19
EXAN
07/05/19
DOWNGRADE
EXAN
Neutral
Reckitt Benckiser downgraded to Neutral from Outperform at Exane BNP Paribas
Exane BNP Paribas analyst Jeff Stent downgraded Reckitt Benckiser to Neutral from Outperform and lowered his price target for the shares to 63 pounds from 73 pounds.
10/16/19
BREN
10/16/19
INITIATION
BREN
Buy
Reckitt Benckiser re-initiated with a Buy at Berenberg
Berenberg analyst Fulvio Cazzol re-initiated coverage of Reckitt Benckiser with a Buy rating and 7,420 pence price target. The analyst thinks household and personal goods companies could outperform the market by 10% over the next 12 months.
10/11/19
REDB
10/11/19
DOWNGRADE
REDB
Sell
Reckitt Benckiser downgraded to Sell from Neutral at Redburn
Redburn analyst Chris Pitcher downgraded Reckitt Benckiser to Sell from Neutral.
09/18/19
MSCO
09/18/19
NO CHANGE
MSCO
EU Household & Personal Care sector downgraded to In-Line at Morgan Stanley
Morgan Stanley analyst Richard Taylor downgraded the European Household & Personal Care, or HPC, sector to In-Line from Attractive to reflect a fading pricing environment in the second half of 2019 and competitive pressures that he sees increasing. Procter & Gamble (PG), after nearly 10 years of losing share to the big players in Europe, is now growing fast and gaining share under new management, Taylor tells investors. His least preferred name in the group is Henkel (HENKY), on which he has an Underweight rating. Other European HPC companies include Unilever (UN, UL), Reckitt Benckiser (RBGLY) and L'Oreal (LRLCY).
RNLSY Renault
$0.00

(0.00%)

10/18/19
SOCG
10/18/19
DOWNGRADE
SOCG
Hold
Renault downgraded to Hold from Buy at Societe Generale
Societe Generale analyst Stephen Reitman downgraded Renault to Hold from Buy with a price target of 55 euros.
08/05/19
JEFF
08/05/19
DOWNGRADE
JEFF
Underperform
Renault downgraded to Underperform from Buy at Jefferies
Jefferies analyst Philippe Houchois double downgraded Renault o Underperform from Buy and lowered his price target for the shares to 42 euros from 74 euros. The analyst sees "unclear compliance roadmaps, below normal average earnings and balance sheet risk on potential cash burn."
07/15/19
GSCO
07/15/19
INITIATION
GSCO
Neutral
Renault initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst George Galliers initiated Renault with a Neutral rating and a price target of EUR 59. The analyst says the company's medium term savings plan is running "slightly behind" after it gave some support to its suppliers last year, but expects the effort to remain a tailwind. Galliers adds that Renault's revenue growth from regions outside of Europe could be pressured given the recent restrictions on sales in Iran as well as the negative sales developments in China.
10/17/19
DBAB
10/17/19
DOWNGRADE
DBAB
Hold
Renault downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Renault to Hold from Buy with a price target of 60 euros citing "too many uncertainties" following the company's profit warning.

TODAY'S FREE FLY STORIES

03:30
01/20/20
01/20
03:30
01/20/20
03:30
General news
FX Action: USD-CAD ebbed fractionally lower »

FX Action: USD-CAD ebbed…

03:05
01/20/20
01/20
03:05
01/20/20
03:05
General news
Asian Market Update: »

Asian Market Update:…

03:05
01/20/20
01/20
03:05
01/20/20
03:05
General news
FX Update: The dollar has seen modest weakness »

FX Update: The dollar has…

FB

Facebook

$222.01

0.23 (0.10%)

16:50
01/19/20
01/19
16:50
01/19/20
16:50
Periodicals
Facebook blames technical error for vulgar translation, Reuters reports »

Facebook blamed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 29

    Jan

SPY

SPDR S&P 500 ETF Trust

$331.98

1.08 (0.33%)

, SPX

S&P 500

$0.00

(0.00%)

16:43
01/19/20
01/19
16:43
01/19/20
16:43
Periodicals
China to increase U.S. imports according to 'market principles,' Reuters reports »

China will negotiate with…

SPY

SPDR S&P 500 ETF Trust

$331.98

1.08 (0.33%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$510.34

-3.065 (-0.60%)

16:33
01/19/20
01/19
16:33
01/19/20
16:33
Periodicals
Tesla closer to opening first European factory with property deal, Reuters says »

Tesla has agreed to buy a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 24

    Feb

  • 23

    Mar

  • 23

    Mar

JPM

JPMorgan

$138.15

0.89 (0.65%)

, BNPQY

BNP Paribas

$0.00

(0.00%)

16:28
01/19/20
01/19
16:28
01/19/20
16:28
Periodicals
JPMorgan to acquire former BNP building in Paris, Bloomberg reports »

JPMorgan (JPM) is buying…

JPM

JPMorgan

$138.15

0.89 (0.65%)

BNPQY

BNP Paribas

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 25

    Feb

  • 14

    Apr

BAC

Bank of America

$34.70

-0.03 (-0.09%)

16:25
01/19/20
01/19
16:25
01/19/20
16:25
Periodicals
CEO tells FT Bank of America aims to 'double' slice of U.S. retail business »

Bank of America can…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 15

    Apr

CEL

Cellcom Israel

$3.18

(0.00%)

16:16
01/19/20
01/19
16:16
01/19/20
16:16
Hot Stocks
Cellcom Israel announces CTO resignation »

Cellcom Israel announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRCA

Verrica Pharmaceuticals

$15.94

0.21 (1.34%)

16:12
01/19/20
01/19
16:12
01/19/20
16:12
Hot Stocks
Verrica announces presentation of data from Phase 3 CAMP trials of VP-102 »

Verrica Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

SO

Southern Company

$67.25

1.08 (1.63%)

, XEL

Xcel Energy

$65.38

0.34 (0.52%)

16:08
01/19/20
01/19
16:08
01/19/20
16:08
Hot Stocks
Southern Power closes sale of Mankato Energy Center to Xcel Energy »

Southern Power, a…

SO

Southern Company

$67.25

1.08 (1.63%)

XEL

Xcel Energy

$65.38

0.34 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

LIZI

Lizhi

$11.72

(0.00%)

, DNK

Phoenix Tree

$13.50

(0.00%)

09:10
01/19/20
01/19
09:10
01/19/20
09:10
On The Fly
Opening Day: China's Lizhi, Phoenix Tree flat in trading debut »

Lizhi (LIZI), one of…

LIZI

Lizhi

$11.72

(0.00%)

DNK

Phoenix Tree

$13.50

(0.00%)

VEL

Velocity Financial

$13.58

(0.00%)

IMAB

I-MAB

$12.90

(0.00%)

BSBK

Bogota Financial

$11.70

0.195 (1.70%)

CSPR

Casper Sleep

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLGT

Teligent

$0.40

-0.0025 (-0.62%)

15:53
01/18/20
01/18
15:53
01/18/20
15:53
Conference/Events
Teligent to hold a special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

AYTU

Aytu BioScience

$0.80

0.0014 (0.18%)

15:48
01/18/20
01/18
15:48
01/18/20
15:48
Conference/Events
Aytu BioScience to hold a special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

DVA

DaVita

$79.45

0.43 (0.54%)

15:32
01/18/20
01/18
15:32
01/18/20
15:32
Conference/Events
DaVita to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

TSM

TSMC

$58.58

-0.18 (-0.31%)

09:16
01/18/20
01/18
09:16
01/18/20
09:16
Periodicals
Taiwan tech stocks can ignore China's bluster for now, Barron's says »

China's government…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$31.20

0.7 (2.30%)

, APO

Apollo Global

$50.35

1.26 (2.57%)

09:03
01/18/20
01/18
09:03
01/18/20
09:03
Periodicals
KKR undervalued compared with peers, Barron's says »

KKR (KKR) gained 50% last…

KKR

KKR

$31.20

0.7 (2.30%)

APO

Apollo Global

$50.35

1.26 (2.57%)

ARES

Ares Management

$37.29

0.47 (1.28%)

BX

Blackstone

$60.79

0.62 (1.03%)

CG

Carlyle Group

$33.30

0.36 (1.09%)

HLNE

Hamilton Lane

$67.25

-0.02 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 30

    Jan

  • 31

    Jan

  • 31

    Jan

  • 04

    Feb

  • 04

    Feb

  • 05

    Feb

  • 13

    Feb

  • 17

    Feb

  • 26

    Feb

SPCE

Virgin Galactic

$15.65

0.685 (4.58%)

, TWNK

Hostess Brands

$14.03

0.02 (0.14%)

08:56
01/18/20
01/18
08:56
01/18/20
08:56
Periodicals
'Blank-check' companies hot on Wall Street, Barron's says »

More than a quarter of…

SPCE

Virgin Galactic

$15.65

0.685 (4.58%)

TWNK

Hostess Brands

$14.03

0.02 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 04

    Mar

GOOG

Alphabet

$1,480.28

28.34 (1.95%)

, NFLX

Netflix

$339.56

0.89 (0.26%)

08:47
01/18/20
01/18
08:47
01/18/20
08:47
Periodicals
Peacock's pricing might be 'killer feature,' Barron's says »

This week, Peacock…

GOOG

Alphabet

$1,480.28

28.34 (1.95%)

NFLX

Netflix

$339.56

0.89 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$47.48

0.62 (1.32%)

GOOGL

Alphabet Class A

$1,479.12

29.29 (2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

  • 23

    Jan

  • 03

    Feb

  • 03

    Feb

  • 10

    Feb

JWN

Nordstrom

$40.34

-0.15 (-0.37%)

, WMT

Walmart

$114.93

-0.96 (-0.83%)

08:36
01/18/20
01/18
08:36
01/18/20
08:36
Periodicals
Casper IPO highlights tech's promise, troubles, Barron' says »

Mattresses have been…

JWN

Nordstrom

$40.34

-0.15 (-0.37%)

WMT

Walmart

$114.93

-0.96 (-0.83%)

CSPR

Casper Sleep

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 18

    Feb

BA

Boeing

$324.11

-7.89 (-2.38%)

, DDAIF

Daimler AG

$0.00

(0.00%)

08:12
01/18/20
01/18
08:12
01/18/20
08:12
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

BA

Boeing

$324.11

-7.89 (-2.38%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$13.76

-0.14 (-1.01%)

VWAGY

Volkswagen

$0.00

(0.00%)

FSLR

First Solar

$53.51

-0.42 (-0.78%)

AAPL

Apple

$318.66

3.33 (1.06%)

DQ

Daqo New Energy

$53.61

-0.025 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 29

    Jan

SPOT

Spotify

$148.20

-3.59 (-2.37%)

18:15
01/17/20
01/17
18:15
01/17/20
18:15
Periodicals
Spotify in talks to acquire The Ringer, WSJ reports »

Spotify is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

CE

Celanese

$117.54

-0.53 (-0.45%)

18:00
01/17/20
01/17
18:00
01/17/20
18:00
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

BYND

Beyond Meat

$109.20

-1.16 (-1.05%)

17:58
01/17/20
01/17
17:58
01/17/20
17:58
Periodicals
Beyond Meat rival gets green light in Canada, The Star says »

Impossible Foods, a maker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBD

Diebold

$11.09

-0.49 (-4.23%)

17:42
01/17/20
01/17
17:42
01/17/20
17:42
Periodicals
Breaking Periodicals news story on Diebold »

Diebold Nixdorf divests…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.